Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2002
11/28/2002WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002WO2002078641A3 Pyrrolidine sulfonamides
11/28/2002WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002WO2002024924A3 Protein phosphatases
11/28/2002WO2002020002A3 A method for treating allergies
11/28/2002WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002US20020177581 Novel anti-inflammatory androstane derivative
11/28/2002US20020177213 Tissue plasminogen activator-like protease
11/28/2002US20020176888 Oral dosage forms
11/28/2002US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002US20020176846 Storage stable powder compositions of interleukin-4 receptor
11/28/2002CA2448045A1 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002CA2447600A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002CA2447598A1 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446049A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002CA2445789A1 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002CA2443287A1 Methods for regulating bacteria
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2427619A1 Pharmaceutically active isoindoline derivatives
11/27/2002EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002EP1259495A2 Indane derivatives and their use as cell adhesion inhibitors
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259223A1 Protein matrix materials, devices and methods of making and using thereof
11/27/2002EP1259222A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
11/27/2002EP1109557B1 Use of cetirizine for preventing the onset of asthma
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382154A Basic monocyclic compounds having NK2 antagonist action processes for their preparation and formulations containing them
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382141A 1,8-naphthyridine derivatives
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection
11/27/2002CN1382042A Treatment of emphysema using RAR selective retinoid agonists
11/27/2002CN1381255A Compoiste bear gall spray for treating rhinocleisis and its preparing process
11/27/2002CN1381252A Chines medicine for treating silicosis
11/27/2002CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them
11/27/2002CN1094764C Traditional Chinese medicinal powder for treating pharyngolaryngeeal disease
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002US6486321 Epoxidation; quaternization
11/26/2002US6486203 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
11/26/2002US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002US6486189 Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/26/2002US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002US6486135 Nucleic acid respiratory syncytial virus vaccines
11/26/2002US6485755 Methods of using electron active compounds for managing cancer
11/26/2002US6485720 Transgene expression systems
11/26/2002CA2262502C 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
11/26/2002CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/26/2002CA2240717C Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
11/21/2002WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 878